Since inception, Alzheimer's Disease Research has awarded nearly $170 million to research projects on the causes, prevention and treatment of Alzheimer’s disease. We fund unique, well-described, methodologically sound research into basic, translational, clinical, and behavioral/social aspects of Alzheimer’s disease, including immunity and inflammation, biomarkers, and sex-based studies.

Alzheimer's Disease Research currently supports 167 research projects worldwide, which represents more than $45 million investment in promising ideas. We take a 360° approach to fund innovative scientific research worldwide to defeat Alzheimer’s, exploring the full range of scientific paths toward better treatments and ultimately a cure. Alzheimer's Disease Research grantees are covering the spectrum of possibilities and bringing new hope to individuals and families who suffer from this disease.

Here are our strengths:

• Alzheimer's Disease Research has steadily increased the number of applicants to receive research grants in numbers and quality to make sure no stone is left unturned to find a cure.

• Applicants for research grants are encouraged from scientists within and outside of academic institutions.

• The typical Alzheimer's Disease Research grant goes to a promising, emerging scientist in an exceptional research environment where he/she will receive needed support for the project, as well as for career development.

• Alzheimer's Disease Research-supported findings are consistently cited at twice the frequency of other scientists’ works and the majority of awardees go on to garner increased interest and ten times the amount of their initial funding from larger sources, such as the National Institutes of Health (NIH) and industry sponsors. This 1,000 percent return on our investment reflects the excellence of funding choices made by our Alzheimer's Disease Research Scientific Review Committee and affirms ADR's role as a trailblazer in Alzheimer’s research.

• The program is designed to pointing the most outstanding young scientists in the direction of lasting careers in Alzheimer’s research, with the expectation that their collaboration and accomplishments continue to build.

• Notably, Alzheimer's Disease Research funded the early research of two separate Nobel Prize winners, Stanley Prusiner, MD (Nobel Prize in Physiology or Medicine, 1997) and Paul Greengard, PhD, (Nobel Prize in Physiology or Medicine, 2000). Both Nobel laureates have served as Honorary Members of BrightFocus' Board of Directors.

You can show your support for more than 6 million Americans fighting this memory-stealing disease and their families by donating to Alzheimer's Disease Research through your workplace giving program.